Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

  • Salah-Eddin Al-Batran1Email author,
  • Thorsten O. Goetze1,
  • Daniel W. Mueller1,
  • Arndt Vogel2,
  • Michael Winkler3,
  • Sylvie Lorenzen4,
  • Alexander Novotny5,
  • Claudia Pauligk1,
  • Nils Homann6,
  • Thomas Jungbluth7,
  • Christoph Reissfelder8,
  • Karel Caca9,
  • Steffen Retter10,
  • Eva Horndasch11,
  • Julia Gumpp12,
  • Claus Bolling13,
  • Karl-Hermann Fuchs14,
  • Wolfgang Blau15,
  • Winfried Padberg16,
  • Michael Pohl17,
  • Andreas Wunsch18,
  • Patrick Michl19,
  • Frank Mannes20,
  • Matthias Schwarzbach21,
  • Harald Schmalenberg22,
  • Michael Hohaus23,
  • Christian Scholz24,
  • Christoph Benckert25,
  • Jorge Riera Knorrenschild26,
  • Veit Kanngießer27,
  • Thomas Zander28,
  • Hakan Alakus29,
  • Ralf-Dieter Hofheinz30,
  • Claus Roedel31,
  • Manish A. Shah32,
  • Mitsuru Sasako33,
  • Dietmar Lorenz34,
  • Jakob Izbicki35,
  • Wolf O. Bechstein36,
  • Hauke Lang37 and
  • Stefan P. Moenig38
Contributed equally
BMC Cancer201717:893

https://doi.org/10.1186/s12885-017-3918-9

Received: 16 June 2017

Accepted: 14 December 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 Jun 2017 Submitted Original manuscript
13 Jul 2017 Author responded Author comments - Salah-Eddin Al-Batran
Resubmission - Version 2
13 Jul 2017 Submitted Manuscript version 2
5 Nov 2017 Author responded Author comments - Salah-Eddin Al-Batran
Resubmission - Version 3
5 Nov 2017 Submitted Manuscript version 3
3 Dec 2017 Author responded Author comments - Salah-Eddin Al-Batran
Resubmission - Version 4
3 Dec 2017 Submitted Manuscript version 4
Publishing
14 Dec 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3918-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main, Germany
(2)
Department of Internal Medicine, Hannover Medical School, Hannover, Germany
(3)
Department of Surgery, Hannover Medical School, Hannover, Germany
(4)
Department of Internal Medicine, Klinikum rechts der Isar der TU München, Munich, Germany
(5)
Department of Surgery, Klinikum rechts der Isar der TU München, Munich, Germany
(6)
Department of Internal Medicine II, Academic Teaching Hospital Wolfsburg, Wolfsburg, Germany
(7)
Department of Surgery, Academic Teaching Hospital Wolfsburg, Wolfsburg, Germany
(8)
Department of Surgery, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
(9)
Department of Internal Medicine, Klinikum Ludwigsburg, Ludwigsburg, Germany
(10)
Department of Surgery, Klinikum Ludwigsburg, Ludwigsburg, Germany
(11)
Department of Internal Medicine, Kliniken des Landkreises Neumarkt, Neumarkt, Germany
(12)
Department of Surgery, Kliniken des Landkreises Neumarkt, Neumarkt, Germany
(13)
Department of Internal Medicine, Agaplesion Markus Krankenhaus Frankfurter, Diakonie Kliniken gGmbH, Frankfurt, Germany
(14)
Department of Surgery, Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH, Frankfurt, Germany
(15)
Department of Medical Oncology, Gießen University Hospital, Gießen, Germany
(16)
Department of Surgery, Gießen University Hospital, Gießen, Germany
(17)
Department of Internal Medicine, Ruhr-University Bochum, Bochum, Germany
(18)
Department of Surgery, Ruhr-University Bochum, Bochum, Germany
(19)
Department of Medical Oncology, Halle University Hospital, Halle (Saale), Germany
(20)
Department of Internal Medicine, Halle University Hospital, Halle, Germany
(21)
Department of Surgery, Klinikum Frankfurt Höchst, Frankfurt, Germany
(22)
Department of Internal Medicine IV, Städtisches Klinikum Dresden, Dresden, Germany
(23)
Department of Surgery, Städtisches Klinikum Dresden, Dresden, Germany
(24)
Department of Medical Oncology, Vivantes Klinikum Am Urban Berlin, Berlin, Germany
(25)
Department of Surgery, Vivantes Klinikum Am Urban Berlin, Berlin, Germany
(26)
Department of Medical Oncology, Marburg University Hospital, Marburg, Germany
(27)
Department of Surgery, Marburg University Hospital, Marburg, Germany
(28)
Department of Internal Medicine, University Hospital Köln, Köln, Germany
(29)
Department of Surgery, University Hospital Köln, Köln, Germany
(30)
University Medical Center Mannheim, Mannheim, Germany
(31)
Department of Radiation- Oncology, Frankfurt University Hospital, Frankfurt, Germany
(32)
Department of Medicine Hematology and Oncology, Weill Cornell Medicine, New York, USA
(33)
Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan
(34)
Department of General and Visceral Surgery, Sana- Klinikum Offenbach, Hamburg, Germany
(35)
Department of Surgery, Hamburg University Hospital, Hamburg, Germany
(36)
Department of Surgery, Frankfurt University Hospital, Hamburg, Germany
(37)
Department of Surgery, Mainz University Hospital, Mainz, Germany
(38)
Hôpitaux Universitaires de Genève, Service de Chirurgie viscéral, Genève, Switzerland

Advertisement